Susceptibility to Electronic Cigarette and Consumption Patterns in Adolescents.

The use of electronic cigarettes (ECs) is a major problem globally. Susceptibility and curiosity are important factors that develop prior to the onset of substance use, such as ECs, and are therefore considered as predictors. Both factors are used to obtain an extended index of susceptibility (ESIe-c), which allows the identification of adolescents who are at risk of starting to use these devices. The aim of this study was to determine the prevalence of EC consumption and to assess the association of possible predictors with susceptibility to use and experimentation with ECs among adolescents. A cross-sectional study was carried out in 377 adolescents (53.0% female). Participants were compared according to their experimentation with ECs. A total of 45.9% had already used electronic cigarettes, and 20.8% were current users. Among those who had not tried electronic cigarettes, 43.3% had a medium-high susceptibility to EC initiation. Consumption among close friends, receiving offers of consumption and alcohol consumption were associated with initiation. There was an inverse association between a medium susceptibility index electronic cigarette score and the consumption of cigarettes and positive affect; on the other hand, the lack of premeditation was associated with a higher susceptibility index score. Intrapersonal factors and social factors seem to influence the ESIe-c and onset of EC use, respectively. The main conclusion in this study is that susceptibility is influenced by intrapersonal factors such as affectivity and impulsivity through the lack of premeditation, and by social factors such as EC consumption by best friends.

Gender differences in susceptibility to smoking among high school students.

AIMS: To analyse the degree of susceptibility to smoking according to gender in students between 12 and 16 years of age and study the role of factors associated with gender and the extended index of susceptibility to smoking. DESIGN: Cross-sectional study. METHODS: Between November 2019 and March 2020, 12- to 16-year-old students were recruited from three educational centres in western Spain. Sociodemographic, environmental, social and personal variables were analysed. The value of the extended index of susceptibility to smoking was calculated, and the associations between the students' genders and smoking susceptibility were studied. Multinomial logistic regression was used to study associations between the independent variables and Expanded Susceptibility Index (ESSI) results. The roles of factors in this association were explored through mediation analysis. RESULTS: A total of 364 students participated in the study (53% females). A total of 79.3% of females and 61.4% of males presented a medium-high level of the extended index of susceptibility. Females reported greater cigarette use (28% vs. 12.3%), hookah (19.9% vs 9.9%) and alcohol consumption (20.7% risk alcohol consumption). They obtained higher scores on the impulsivity scale in the urgency domain and the negative affect scale. Regardless of other factors, females showed more than double the smoking susceptibility (aOR: 2.05, 95% CI: 1.03-4.07, p = .041). Mediation analysis showed that gender had a total effect on the extended susceptibility index ß = .023 (95% CI: 0.07-0.38, p = .01). The effect appeared to be mediated only by having smoking friends (0.08; 95% CI: 0.03-0.15, p = .001). CONCLUSIONS: The greater susceptibility to smoking found in females may be related to a greater influence of smoking among friends. IMPACT: These results show that smoking friends have a strong influence among adolescent females; therefore, developing preventive programmes with gender approaches aimed at reducing the influence of these environmental factors would be of interest.

Childbirth Satisfaction during the COVID-19 Pandemic in a Hospital in Southwestern Spain.

Satisfaction, in relation to care received, is a good indicator of quality of care. The objective of this study was to analyze the degree of satisfaction with childbirth and postpartum care as reported by women from one hospital in southwestern Spain during the COVID-19 pandemic. Factors that influenced care were also examined. A cross-sectional study was carried out between the months of October 2020 and February 2021. Satisfaction was measured through the COMFORTS scale, validated in Spanish. A final sample of 116 women was included in the study. The mean age was 32.08 (±4.68) years. A total of 111 (95.69%) women were satisfied or very satisfied with the care received. The median satisfaction score was higher among multiparous women (187 (199-173)) than among primiparous women (174 (193-155.50)) (p = 0.003). Differences in satisfaction were found as a function of the use of epidural analgesia, being higher among women who had planned its use but ultimately did not use it (188 (172.50-199.75)) or who planned its use and did (186 (169.50-198)) than among those who had not planned to use epidural analgesia but ultimately received it (173.50 (187.50-146.25)) or those who did not use it, as planned, before childbirth (172 (157-185)) (p = 0.020). Overall satisfaction rate between SARS-CoV-2-negative women assisted was high. Parity and use of epidural analgesia were two factors influencing satisfaction scores in our sample.

Factors Associated with the Acceptance of New Technologies for Ageing in Place by People over 64 Years of Age.

BACKGROUND: In the context of growing population ageing, technologies aimed at helping people age in place play a fundamental role. Acceptance of the implementation of technological solutions can be defined as the intention to use a technology or the effective use of it. Approaches based on the technology acceptance model (TAM) have been shown to have good predictive power for pre-implementation attitudes towards new technologies. OBJECTIVE: To analyze the degree of acceptability of the use of new technologies for ageing in place and the factors associated with greater acceptance in people older than 64 years. METHODOLOGY: A descriptive cross-sectional study was carried out. Sociodemographic, clinical and environmental variables, architectural barriers, social risk and quality of life, degree of autonomy, morbidity, and risk of falls were collected in a population sample over 64 years of age in a large region of western Spain. The degree of acceptance of the use of technologies was measured through a scale based on the TAM. RESULTS: Of the 293 people included in the study, 36.2% exhibited a high acceptability of new technologies, 28.3% exhibited a medium acceptability, and 35.5% exhibited a low acceptability. Of all the factors, age, education level, and living alone were significantly associated with high acceptance in the adjusted analyses. CONCLUSIONS: Younger age, a higher education level, and living alone are factors associated with a greater degree of acceptance of the use of technologies for ageing in place.

Acceso a los dispositivos autoajustables para el tratamiento de apneas del sueño durante la pandemia por COVID-19 / Access to auto-adjustable positive airway pressure devices for the treatment of obstructive sleep apnea during the COVID-19 pandemic

Resumen El empleo de presión positiva en la vía aérea es el tratamiento de elección en apneas obstructIvas del sueño. Desde el inicio de la pandemia por el virus SARS- CoV-2 las recomendaciones fueron evitar la administración en el laboratorio de sueño de estas terapias e iniciar tratamiento con equipos autoajus tables. El objetivo fue evaluar el acceso a los equipos autoajustables en el contexto epidemiológico actual. Se incluyeron 66 pacientes, la edad media fue de 50.7 ± 12.8, 44% hombres, con un IAH de 35.5 (22.7-64.2) y un IMC de 38.3 (32.8-46.1). El 45% tenía cobertura médica. De los 50 (74%) que tramitaron el equipo, 19 (29%) accedió al dispositivo. La cobertura médica fue la única variable significativa entre los que accedieron y los que no: 54% vs. 21% (p = 0.016). La demora entre el inicio del trámite y el del tratamiento fue 31 ± 21 días en los que tenían cobertura médica y 65 ± 35 días en aquellos sin cobertura (p = 0.008). El acceso a terapias autoajustables durante la pandemia por COVID estuvo por debajo del de nuestra experiencia previa y de lo descripto en otros trabajos con terapias fijas. Cabe plantearse si esta disminución es producto de la pandemia e independiente del tipo de terapia, o está en relación directa a los mayores costos de los equipos autoajustables o falta de convenio de los mismos por parte de los organismos proveedores.

Abstract The use of positive airway pressure is the treatment of choice for obstructive sleep apnea. Since the beginning of SARS-CoV-2 virus pandemic the recommenda tions were to avoid the administration of this therapy in the sleep laboratory and to start treatment with auto-adjustable continuous positive airway pressure devices. The objective was to evaluate access to these devices in the current epidemiological context. Sixty-six patients were included, the mean age was 50.7 ± 12.8, 44% men with an AHI of 35.5 (22.7-64.2) and a BMI of 38.3 (32.8-46.1). Forty-five percent had health insurance. Of the 50 (74%) who processed the device, 19 (29%) had access. Health insurance was the only significant variable between those who had access to the device and those who did not: 54% vs. 21% (p=0.016). The delay between the beginning of the procedure to access the device and the start of treatment was 31 ± 21 in patients who had medical insurance and 65 ± 35.2 in those who did not (p = 0.008). Access to auto-adjustable therapies during the COVID-19 pandemic was below our former experience and that described in other studies with fixed therapies. It is worth considering whether this decrease is a product of the pandemic and indepen dent of the type of therapy or is directly related to the higher costs of self-adjustable devices or to a lack of coverage from the healthcare providers.

[Access to auto-adjustable positive airway pressure devices for the treatment of obstructive sleep apnea during the COVID-19 pandemic]. / Acceso a los dispositivos autoajustables para el tratamiento de apneas del sueño durante la pandemia por COVID-19.

The use of positive airway pressure is the treatment of choice for obstructive sleep apnea. Since the beginning of SARS-CoV-2 virus pandemic the recommendations were to avoid the administration of this therapy in the sleep laboratory and to start treatment with autoadjustable continuous positive airway pressure devices. The objective was to evaluate access to these devices in the current epidemiological context. Sixty-six patients were included, the mean age was 50.7 ± 12.8, 44% men with an AHI of 35.5 (22.7-64.2) and a BMI of 38.3 (32.8-46.1). Forty-five percent had health insurance. Of the 50 (74%) who processed the device, 19 (29%) had access. Health insurance was the only significant variable between those who had access to the device and those who did not: 54% vs. 21% (p=0.016). The delay between the beginning of the procedure to access the device and the start of treatment was 31 ± 21 in patients who had medical insurance and 65 ± 35.2 in those who did not (p = 0.008). Access to auto-adjustable therapies during the COVID-19 pandemic was below our former experience and that described in other studies with fixed therapies. It is worth considering whether this decrease is a product of the pandemic and independent of the type of therapy or is directly related to the higher costs of self-adjustable devices or to a lack of coverage from the healthcare providers.

El empleo de presión positiva en la vía aérea es el tratamiento de elección en apneas obstructIvas del sueño. Desde el inicio de la pandemia por el virus SARS- CoV-2 las recomendaciones fueron evitar la administración en el laboratorio de sueño de estas terapias e iniciar tratamiento con equipos autoajustables. El objetivo fue evaluar el acceso a los equipos autoajustables en el contexto epidemiológico actual. Se incluyeron 66 pacientes, la edad media fue de 50.7 ± 12.8, 44% hombres, con un IAH de 35.5 (22.7-64.2) y un IMC de 38.3 (32.8-46.1). El 45% tenía cobertura médica. De los 50 (74%) que tramitaron el equipo, 19 (29%) accedió al dispositivo. La cobertura médica fue la única variable significativa entre los que accedieron y los que no: 54% vs. 21% (p = 0.016). La demora entre el inicio del trámite y el del tratamiento fue 31 ± 21 días en los que tenían cobertura médica y 65 ± 35 días en aquellos sin cobertura (p = 0.008). El acceso a terapias autoajustables durante la pandemia por COVID estuvo por debajo del de nuestra experiencia previa y de lo descripto en otros trabajos con terapias fijas. Cabe plantearse si esta disminución es producto de la pandemia e independiente del tipo de terapia, o está en relación directa a los mayores costos de los equipos autoajustables o falta de convenio de los mismos por parte de los organismos proveedores.

Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis.

There are few data regarding the repercussion in the pulmonary function of patients who had severe or critical COVID-19 pneumonia. The objective was to describe these patients' pulmonary function and establish an association with the severity of the disease (patients with severe or critical pneumonia), the presence of comorbidities, the tomographic involvement and the persistence of dyspnoea. Fifty-five patients were included, 40 (73%) male, media of age 54.9 (11.6) years old and body mass index (BMI) 33.1 (6.09) kg/ m2. Fifty (90%) had 1 comorbidity, obesity 67%, arterial hypertension 36%, and diabetes mellitus 35%. Twentyfive (45%) had critical pneumonia. Fifteen (27%) had a spirometric alteration that suggested restriction and 32 (58%) had gas exchange defect. The latter had forced volume capacity (FVC), forced expiratory volume in the first second (FEV1) and carbon monoxide diffusion capacity (DLCO) values significantly lower. Ninety percent presented some degree of involvement in the chest CT scan, ground glass-opacities the most frequent finding. A moderate negative correlation was found between the severity of the tomographic involvement and the DLCO levels. Thirty patients (55%) referred some degree of dyspnoea. Patients with this symptom had DLCO and KCO values below those who did not have dyspnoea: 70.5 vs. 85.1 p = 0.02 and 88 vs. 104 p = 0.02. The presence of abnormal gas exchange is the main characteristic of patients with pulmonary sequelae due to COVID-19. Our study does not show either predictor of evolution towards pulmonary sequelae or an association with the severity of the disease.

Se conocen pocos datos acerca de la repercusión en la función pulmonar de pacientes que cursaron una neumonía grave o crítica por COVID-19. El objetivo fue describir la función pulmonar de estos pacientes y establecer si existe asociación con la gravedad (neumonía grave o crítica), comorbilidades, compromiso tomográfico y persistencia de disnea. Se incluyeron 55 pacientes, 40 (73%) varones, media de edad 54.9 (11.6) años e índice de masa corporal (IMC) 33.1 (6.09) kg/m2. Cincuenta (90%) tenían una comorbilidad, obesidad 67%, hipertensión arterial 36% y diabetes mellitus 35%. Veinticinco (45%) presentaron neumonía crítica. Se hallaron 15 (27%) con una alteración que sugiere restricción y 32 (58%) presentaron trastorno del intercambio gaseoso. Aquellos con trastorno del intercambio gaseoso, tenían valores de capacidad vital forzada (FVC), volumen espiratorio forzado en el primer segundo (FEV1) y difusión de monóxido de carbono (DLCO) significativamente menores. El 90% tenía algún grado de compromiso en TAC de tórax siendo vidrio esmerilado el hallazgo más frecuente. Se encontró moderada correlación negativa entre gravedad del compromiso tomográfico y nivel de DLCO. A la consulta, 30 (55%) referían algún grado de disnea. Los pacientes con disnea presentaban valores de DLCO y KCO inferiores respecto a los que no referían disnea 70.5 vs. 85.1 p = 0.02 y 88 vs. 104 p = 0.02. La presencia de intercambio anormal de gases es la característica principal de los pacientes con secuelas pulmonares por COVID-19. De nuestro trabajo no surgen predictores para evolución hacia secuela pulmonar ni pudimos asociarlo a la gravedad de la enfermedad.

Evaluation of the pulmonary function of patients with severe coronavirus 2019 disease three months after diagnosis / Evaluación de la función pulmonar de pacientes con enfermedad grave por coronavirus 2019 tres meses después del diagnóstico

Abstract There are few data regarding the repercussion in the pulmonary function of patients who had severe or critical COVID-19 pneumonia. The objective was to describe these patients´ pulmonary function and establish an association with the severity of the disease (patients with severe or critical pneumonia), the presence of comorbidities, the tomographic involvement and the persistence of dyspnoea. Fifty-five patients were included, 40 (73%) male, media of age 54.9 (11.6) years old and body mass index (BMI) 33.1 (6.09) kg/m2. Fifty (90%) had 1 comorbidity, obesity 67%, arterial hypertension 36%, and diabetes mellitus 35%. Twenty-five (45%) had critical pneumonia. Fifteen (27%) had a spirometric alteration that suggested restriction and 32 (58%) had gas exchange defect. The latter had forced volume capacity (FVC), forced expiratory volume in the first second (FEV1) and carbon monoxide diffusion capacity (DLCO) values significantly lower. Ninety percent presented some degree of involvement in the chest CT scan, ground glass-opacities the most frequent finding. A moderate negative correlation was found between the severity of the tomographic involvement and the DLCO levels. Thirty patients (55%) referred some degree of dyspnoea. Patients with this symptom had DLCO and KCO values below those who did not have dyspnoea: 70.5 vs. 85.1 p = 0.02 and 88 vs. 104 p = 0.02. The presence of abnormal gas exchange is the main characteristic of patients with pulmonary sequelae due to COVID-19. Our study does not show either predictor of evolution towards pulmonary sequelae or an association with the severity of the disease.

Resumen Se conocen pocos datos acerca de la repercusión en la función pulmonar de pacientes que cursaron una neumonía grave o crítica por COVID-19. El objetivo fue describir la función pulmonar de estos pacientes y establecer si existe asociación con la gravedad (neumonía grave o crítica), comorbilidades, compromiso tomográfico y persistencia de disnea. Se incluyeron 55 pacientes, 40 (73%) varones, media de edad 54.9 (11.6) años e índice de masa corporal (IMC) 33.1 (6.09) kg/m2. Cincuenta (90%) tenían una comorbilidad, obesidad 67%, hipertensión arterial 36% y diabetes mellitus 35%. Veinticinco (45%) presentaron neumonía crítica. Se hallaron 15 (27%) con una alteración que sugiere restricción y 32 (58%) presentaron trastorno del intercambio gaseoso. Aquellos con trastorno del intercambio gaseoso, tenían valores de capacidad vital forzada (FVC), volumen espiratorio forzado en el primer segundo (FEV1) y difusión de monóxido de carbono (DLCO) significativamente menores. El 90% tenía algún grado de compromiso en TAC de tórax siendo vidrio esmerilado el hallazgo más frecuente. Se encontró moderada correlación negativa entre gravedad del compromiso tomográfico y nivel de DLCO. A la consulta, 30 (55%) referían algún grado de disnea. Los pacientes con disnea presentaban valores de DLCO y KCO inferiores respecto a los que no referían disnea 70.5 vs. 85.1 p = 0.02 y 88 vs. 104 p = 0.02. La presencia de intercambio anormal de gases es la característica principal de los pacientes con secuelas pulmonares por COVID-19. De nuestro trabajo no surgen predictores para evolución hacia secuela pulmonar ni pudimos asociarlo a la gravedad de la enfermedad.

Cálculo de predicción de presión de CPAP. Una alternativa ante la dificultad de realizar titulación en el contexto de la pandemia por COVID 19

Resumen Introducción: El tratamiento de elección para el síndrome de apneas hipopneas del sueño (SAHOS) es la presión positiva continua de aire en la vía aérea (CPAP) titulando la presión efectiva que elimine los eventos obstructivos a través de métodos validados. Desde el inicio de la pandemia de COVID 19, se ha recomendado posponer las titulaciones convencionales, indicando en su lugar equipos autoajustables. En nuestra población es dificultoso el acceso a estos dispositivos. Objetivo: Demostrar si existe diferencia entre el nivel de presión de CPAP calculado a partir de una fórmula de predicción y la presión determinada mediante titulación bajo polisomnografía. Materiales y Métodos: Se incluyeron pacientes con SAHOS en los que se realizó una titulación de CPAP efectiva y se comparó con la CPAP calculada por la fórmula de Miljeteig y Hoffstein. Resultados: Se incluyeron registros de historias clínicas de 583 pacientes, (56%) hombres, 51 años (41-61), índice de apneas e hipopneas (IAH) 51.3 (29.2 -84.4), CPAP calculada 9.3 cm H2O vs CPAP efectiva 8 cm H2O (p < 0.0001). Comparando según grado de severidad del SAHOS, la diferencia promedio entre CPAP calculada y CPAP efectiva fue 0.24, 0.21 y 0.41 (diferencias no significativas) para leve, moderado y grave hasta un IAH < 40, en pacientes con un IAH ≥ 40 esta diferencia fue de 1.10 (p < 0.01). Hallamos una aceptable correlación entre la CPAP calculada y CPAP efectiva, coeficiente de correlación intraclase = 0.621 (p < 0.01). Conclusión: Podrían utilizarse cálculos de predicción de presión de CPAP para iniciar tratamiento en pacientes con SAHOS sin acceso a terapias autoajustables en el contexto de la pandemia hasta tanto puedan realizarse las medidas de calibración estándar.

CPAP Pressure Prediction Calculation. An Alternative to the Difficulty of Performing a Titration Within the Context of the COVID19 Pandemic

Abstract Introduction: The treatment of choice for the obstructive sleep apnea-hypopnea syndrome (OSAHS) is continuous positive air pressure in the airway (CPAP), titrating the effective pressure that eliminates obstructive events through validated methods. From the beginning of the COVID 19 pandemic, it has been recommended that conventional titration should be postponed, replacing it with self-adjusting equipment. In our population, access to these devices is difficult. Objective: To show whether there is a difference between the CPAP pressure level calculated through a prediction formula and the pressure determined by titration under polysomnography. Materials and Methods: We included patients with OSAHS who underwent effective CPAP titration and compared it with the cal culated CPAP by the Miljeteig and Hoffstein formula. Results: We included medical records of 583 patients, (56%) men, 51 years (41-61), apnea-hypopnea index (AHI) of 51.3 (29.2 -84.4), calculated CPAP, 9.3 cm H2O vs. effective CPAP, 8 cm H2O (p < 0.0001). Comparing according to the degree of severity of the OSAHS, the average difference between calculated CPAP and effective CPAP was 0.24, 0.21, and 0.41 (non-significant differences) for mild, moderate and severe, up to an AHI < 40; in patients with an AHI ≥ 40 this difference was 1.10 (p < 0.01). We found an ac ceptable correlation between the calculated CPAP and the effective CPAP, with an intraclass correlation coefficient of 0.621, p < 0.01. Conclusion: We could use CPAP pressure prediction calculations to start treatment in patients with OSAHS who don't have access to self-adjusting therapies within the context of the pandemic, until standard calibration measures can be taken.

Effect of a brief motivational intervention in the immediate postpartum period on breastfeeding self-efficacy: Randomized controlled trial.

Brief motivational intervention (bMI) is a therapeutic approach that encourages self-efficacy and may have a positive effect on breastfeeding self-efficacy (BSE). The purpose of this study was to analyze the effectiveness of a bMI in increasing BSE in women who started breastfeeding in the immediate postpartum period and to explore the roles of general self-efficacy and other baseline variables in this relationship. A randomized, parallel-group clinical trial was carried out. A bMI was compared with an educational session on breastfeeding. Changes in BSE and its dimensions and the interaction and mediation/moderation of general self-efficacy and other variables were analyzed. BSE increased in the bMI group from a mean baseline score of 59.14 (±9.35) to 64.62 (±7.91) at 1st month (p < 0.001). An interaction was found in that only women with higher education had an improvement in BSE during the follow-up period that was attributable to the bMI (mean difference between the bMI and the attention control group: 18.25 (95% confidence interval: 5.86-30.19; p = 0.006). This interaction was not found for the changes produced in the intrapersonal thoughts dimension of BSE, whose scores were higher in the bMI group at 3 and 6 months. General self-efficacy exerted a moderating effect on the association of bMI with BSE change. The effect of bMI was no longer significant when the general self-efficacy score was above 84. Thus, bMI is effective in increasing BSE. This effectiveness was limited by the mother's educational level and moderated by baseline general self-efficacy.

Influence of Breastfeeding in the Adaptation of and Absenteeism of Infants in Early Childhood Centers: A Preliminary Study.

Schooling of children between 0 and 3 years old involves a process of adaptation and increases their exposure to infectious diseases, which leads to school absenteeism. Breastfeeding facilitates the development of secure attachment and protects the infant against infections. This study aimed to determine whether breastfeeding facilitates the adaptation of infants between 0 and 3 years old to early childhood center and decreases school absenteeism. A cross-sectional study was carried out by collecting data through a questionnaire, which was filled out by the parents and the childcare professionals. 160 infants participated. 40% of the infants who received infant formula from birth showed dependency behaviors (inconsolable crying or do not leave the caregiver for a long time) at the time of pick-up from the center, compared with 10%, 2.7%, and 2.6% of children breastfed between 0 and 6 months, and more than 6 and 12 months, respectively (p = 0.001). The interquartile range of absenteeism days per episode was 2-3 days for infants fed infant formula versus 1-2 days for those who were breastfed for more than 12 months (p = 0.041). Breastfeeding seems to be associated with fewer dependency behaviors at the time of collection and with fewer days of absence.

[Diffusing capacity for carbon monoxide, guidelines for interpretation]. / Capacidad de difusión de monóxido de carbono, pautas para su interpretación.

The diffusing capacity for carbon monoxide (DLCO) is, after spirometry the standard and noninvasive pulmonary function test of greater clinical use. However, there are substantial errors in the interpretation of the physiological significance of the DLCO, its derived measures and, therefore the clinical significance of its alterations. In addition to the use of different nomenclatures, other sources of confusion have contributed to some negative view of the test. The technical aspects of the DLCO test have the advantage of being well standardized. But unlike what happens with other pulmonary function tests where we have reference values which allow us to determine their "normality or abnormality", it is difficult to apply this route of analysis in the case of DLCO. The central fact in the analysis of DLCO, transference factor for CO (KCO), and alveolar volume (VA) is that for a correct interpretation it is necessary to think about the mechanism by which the pathology induces change. A KCO of 100% can be considered normal in some circumstances or pathological in others and, for the moment, the automated study report cannot discriminate. This article will address the principles of the DLCO test; present different models of analysis submit concrete examples and provide guidelines for their correct interpretation. It is considered essential to carry out an integrated analysis of the DLCO test in relation to other functional tests and clinical data.

La capacidad de difusión de monóxido de carbono (DLCO) es, después de la espirometría, la prueba de función pulmonar rutinaria y no invasiva de mayor utilidad clínica. No obstante, hay sustanciales errores de interpretación del significado fisiológico de la DLCO, de sus medidas derivadas y por consiguiente del significado clínico de sus alteraciones. Además de la utilización de diferentes nomenclaturas, otras fuentes de confusión han contribuido a cierta visión negativa de la prueba. Los aspectos técnicos de la prueba de DLCO tienen la ventaja de estar estandarizados. Pero a diferencia de lo que ocurre con otras pruebas de función pulmonar donde disponemos de valores de referencia que permiten determinar la "normalidad o anormalidad" de las mismas, es difícil aplicar esta vía de análisis en el caso de la DLCO. El hecho central en el análisis de la DLCO, el factor de transferencia para el CO (KCO), y el volumen alveolar (VA) es que para una correcta interpretación es necesario tener en cuenta el mecanismo por el cual la patología induce el cambio. Un KCO del 100% puede ser considerado normal en unas circunstancias o patológico bajo otras y, por el momento, el informe automatizado del estudio no puede discriminar. Este artículo describirá los principios de la prueba de DLCO, presentará diferentes modelos de análisis, expondrá ejemplos concretos y ofrecerá pautas para su correcta interpretación. Se considera indispensable efectuar un análisis integrado de la prueba de DLCO en relación con otras pruebas funcionales y con los datos clínicos.

Capacidad de difusión de monóxido de carbono, pautas para su interpretación / Diffusing capacity for carbon monoxide, guidelines for interpretation

Resumen La capacidad de difusión de monóxido de carbono (DLCO) es, después de la espirometría, la prueba de función pulmonar rutinaria y no invasiva de mayor utilidad clínica. No obstante, hay sustanciales errores de interpretación del significado fisiológico de la DLCO, de sus medidas derivadas y por consiguiente del significado clínico de sus alteraciones. Además de la utilización de diferentes nomenclaturas, otras fuentes de confusión han contribuido a cierta visión negativa de la prueba. Los aspectos técnicos de la prueba de DLCO tienen la ventaja de estar estandarizados. Pero a diferencia de lo que ocurre con otras pruebas de función pulmonar donde disponemos de valores de referencia que permiten determinar la "normalidad o anormalidad" de las mismas, es difícil aplicar esta vía de análisis en el caso de la DLCO. El hecho central en el análisis de la DLCO, el factor de transferencia para el CO (KCO), y el volumen alveolar (VA) es que para una correcta interpretación es necesario tener en cuenta el mecanismo por el cual la patología induce el cambio. Un KCO del 100% puede ser considerado normal en unas circunstancias o patológico bajo otras y, por el momento, el informe automatizado del estudio no puede discriminar. Este artículo describirá los principios de la prueba de DLCO, presentará diferentes modelos de análisis, expondrá ejemplos concretos y ofrecerá pautas para su correcta interpretación. Se considera indispensable efectuar un análisis integrado de la prueba de DLCO en relación con otras pruebas funcionales y con los datos clínicos.

Abstract The diffusing capacity for carbon monoxide (DLCO) is, after spirometry the standard and noninvasive pulmonary function test of greater clinical use. However, there are substantial errors in the interpretation of the physiological significance of the DLCO, its derived measures and, therefore the clinical significance of its alterations. In addition to the use of different nomenclatures, other sources of confusion have contributed to some negative view of the test. The technical aspects of the DLCO test have the advantage of being well standardized. But unlike what happens with other pulmonary function tests where we have reference values which allow us to determine their "normality or abnormality", it is difficult to apply this route of analysis in the case of DLCO. The central fact in the analysis of DLCO, transference factor for CO (KCO), and alveolar volume (VA) is that for a correct interpretation it is necessary to think about the mechanism by which the pathology induces change. A KCO of 100% can be considered normal in some circumstances or pathological in others and, for the moment, the automated study report cannot discriminate. This article will address the principles of the DLCO test; present different models of analysis submit concrete examples and provide guidelines for their correct interpretation. It is considered essential to carry out an integrated analysis of the DLCO test in relation to other functional tests and clinical data.

Economic Analysis of Brief Motivational Intervention Following Trauma Related to Drugs and Alcohol.

BACKGROUND: Very few studies have conducted an economic assessment of brief motivational intervention (BMI) in patients experiencing traumatic injuries related to alcohol and/or substance use. Furthermore, findings concerning the potential long-term economic benefits of BMI applied in nursing are promising but very scarce. OBJECTIVE: The purpose of this study was to analyze the costs and benefits associated with the application of a BMI program by nursing staff to patients hospitalized for trauma related to substance use. METHODS: An analysis of costs and benefits was conducted in a nonrandomized study of a retrospective cohort of patients. An intervention and follow-up (of 10-52 months) of patients between 16 and 70 years of age admitted for traumatic injuries in University Hospital of Granada were carried out with a cohort of 294 patients (intervention = 162 vs. no intervention = 132) between 2011 and 2016. The National Health Service's perspective on the use of medical resources and the costs associated with intervention and recidivism was considered. A cost analysis with a 5-year time frame and a subsequent analysis of sensitivity were conducted. RESULTS: Direct medical costs associated with trauma recidivism were significantly lower in patients who received BMI, as compared to patients who did not receive it, &OV0556;751.82 per patient (95% CI &OV0556;13.15 to &OV0556;1,490.48) in the first year. The cost-benefit ratio of &OV0556;74.92 at 4 years reflects National Health Service savings for each euro invested in BMI. DISCUSSION: The implementation of BMI programs in nursing care may be profitable from an economic standpoint, justifying the inclusion of these programs in hospitals both because of their efficacy and the potential savings incurred by the health system. This study addresses the lack of evidence regarding the economic implications linked to the effectiveness of the intervention to reduce substance use and trauma recidivism. Results identify BMI delivered in hospitals by nurses as a technique that offers the potential for reducing costs linked to trauma recidivism. The research has important practical implications for hospital nurses and doctors.

Association of benzodiazepines, opioids and tricyclic antidepressants use and falls in trauma patients: Conditional effect of age.

INTRODUCTION: The relationship between benzodiazepines, opioids and tricyclic antidepressants and trauma is of great importance because of increased consumption and the growing evidence of a positive association among older adults. The objective of this study was to determine the effect size of the association between the consumption of psychotropic medications /opioids and falls in patients who have suffered trauma by studying the role of other variables in this relationship. METHOD: From 2011 to 2016, the presence of benzodiazepines, opioids and tricyclic antidepressants and other drugs in 1060 patients admitted for trauma at a level I trauma hospital was analysed. Multivariate models were used to measure the adjusted effect size of the association between consumption of benzodiazepines, opioids and tricyclic antidepressants and falls, and the effect of age on this association was studied. RESULTS: A total of 192 patients tested positive for benzodiazepines, opioids and tricyclic antidepressants, with same-level falls being the most frequent mechanism of injury in this group (40.1%), with an odds ratio of 1.96 (1.40-2.75), p < 0.001. Once other covariates were introduced, this association was not observed, leaving only age, gender (woman) and, to a lesser extent, sensory conditions as variables associated with falls. Age acted as an effect modifier between benzodiazepines, opioids and tricyclic antidepressants and falls, with significant effect sizes starting at 51.9 years of age. CONCLUSIONS: The association between the consumption of benzodiazepines, opioids and tricyclic antidepressants and falls in patients admitted for trauma is conditioned by other confounding variables, with age being the most influential confounding variable.

Effectiveness of a brief motivational intervention to increase the breastfeeding duration in the first 6 months postpartum: Randomized controlled trial.

AIMS: To evaluate the effectiveness of a brief motivational intervention to increase the breastfeeding duration in the first 6 months postpartum in mothers who began breastfeeding in the first hour after birth and to explore the role of general and breastfeeding self-efficacy in this relationship. DESIGN: A multi-centre randomized controlled clinical trial. METHODS: Data were collected from February 2018 - March 2019. Women were randomly assigned to an intervention group that received a brief motivational intervention (N = 44) or a control group that was offered standard education on breastfeeding (N = 44). Survival analysis techniques were carried out with a follow-up of 6 months. In addition, the roles of breastfeeding and general self-efficacy in the association between BMI and breastfeeding duration were explored through mediation/moderation analysis. RESULTS: Among 88 randomized patients (mean age, 32.82 years), 81 (92.04%) completed the trial. The survival analyses of exclusive breastfeeding and breastfeeding (exclusive and non-exclusive) showed reductions in the risk of abandonment in the intervention group of 63% (aHR: 0.37 [0.22-0.60] p < .001) and 61% (aHR: 0.39 [0.20-0.78] p = .008), respectively. We found that self-efficacy acted as a moderator of the effect of brief motivational intervention on breastfeeding self-efficacy. A discrete indirect effect of brief motivational intervention through increased breastfeeding self-efficacy was found on breastfeeding duration, with an index of moderated mediation of 0.08 (95% CI: 0.02-0.19). Greater positive variations in the breastfeeding self-efficacy scores during follow-up predicted exclusive and non-exclusive breastfeeding duration. CONCLUSION: A brief motivational intervention conducted in the immediate postpartum period increases breastfeeding and exclusive breastfeeding duration in the first 6 months. Although breastfeeding self-efficacy seems to moderate the effect of brief motivational intervention on the increase in breastfeeding duration, other factors may influence its effectiveness. Further studies could focus on exploring how brief motivational intervention works and whether it also works for pregnant mothers who have not yet decided whether to breastfeed. IMPACT: Brief motivational intervention could be introduced as part of routine care of women who begin breastfeeding to improve the low rates of exclusive breastfeeding at 6 months postpartum. TRIAL REGISTRATION: Unique Protocol ID: Moti003; https://ClinicalTrials.gov ID: NCT03357549.

Brief group-delivered motivational interviewing is equally effective as brief group-delivered cognitive-behavioral therapy at reducing alcohol use in risky college drinkers.

College students are particularly vulnerable to risky alcohol use, which increases their likelihood of developing an alcohol use disorder in the future. As such, preventing and reducing alcohol use among college students should be a priority for health and social policies. This work was aimed to show that brief group-delivered MI is as effective as brief-group CBT at reducing alcohol use in college students. Eighty-nine college students (69 females; mean age = 21.01, SD = 2.85) with risky alcohol use, as measured by the AUDIT-C, were assigned to two groups, receiving three sessions of either brief group-delivered MI or CBT (bMI/bCBT). Alcohol use was assessed 3 and 6 months after the interventions, and analyzed according to an Intention-to-treat design. Changes in alcohol use at both points (relative to baseline) as well as post-intervention scores of intention to continue treatment and satisfaction with the psychologist were compared across groups, using one-sided Bayesian t-tests. Alcohol use decreased in both groups at the 3- and 6-months measurement points (relative to baseline). However, using bCBT superiority as an alternative hypothesis and the absence of such superiority as a point-null hypothesis, the Bayes factors supported the null at both the 3- and the 6-months follow-up (BF01 = 7.13, and BF01 = 5.22 respectively). Furthermore, the intention to continue treatment was substantially higher in the bMI group (BF10 = 9.77). These results are considerably robust to changes in analyses' priors. This study suggests that bCBT is not more effective than bMI at reducing alcohol use in our college student group (in which females are overrepresented). Additionally, bMI showed higher intention to continue treatment scores. The comparable results of brief and group-delivered CBT and MI interventions in alcohol use reduction allows clinicians to select treatments based on their own skills or preferences without any detriment to efficacy.

Effects of Smoking and Physical Activity on the Pulmonary Function of Young University Nursing Students in Cáceres (Spain).

BACKGROUND: The simultaneous effect of physical activity (PA) and smoking on pulmonary function in young people remains unclear. PROPOSE: The aim of this study was to determine the influence of smoking and PA on pulmonary function in young university students in Cáceres, Spain. METHODS: A sample of 120 young nursing students was studied (60 smokers and 60 nonsmokers). All subjects underwent spirometry with a COPD-6 portable device, and their level of PA was quantified using the International Physical Activity Questionnaire. The influence of PA and smoking on pulmonary function was determined by comparing hypotheses. RESULTS: Significant differences were observed between smokers and nonsmokers in terms of percent forced expiratory volume in 1 second, percent forced expiratory volume in 6 seconds, lung age, and the difference between lung age and chronological age (LA-CA) in those who practiced mild PA. In the subjects who performed moderate and vigorous PA, these differences were not noted. In the intragroup analysis, significant differences were observed in smokers in terms of percent forced expiratory volume in 1 second, percent forced expiratory volume in 6 seconds, lung age, and LA-CA; however, in the control group, differences were only observed in terms of lung age and LA-CA. These findings were confirmed in the multivariate analysis. CONCLUSIONS/IMPLICATIONS FOR PRACTICE: Our findings confirmed a deterioration in pulmonary function in smokers who did not perform moderate or vigorous PA. The level of PA performed was positively related to pulmonary function in smokers, whereas in nonsmokers, improvements were only significant in LA-CA.

The effect of central nervous system depressant, stimulant and hallucinogenic drugs on injury severity in patients admitted for trauma / Efecto de las drogas alucinógenas, estimulantes y depresoras del sistema nervioso central sobre la gravedad de la lesión en pacientes ingresados por traumatismos

Objective: The effect of drugs other than alcohol on severity of trauma remains unclear. Pooled data analyses in previous studies that grouped substances with opposite effects on the central nervous system (CNS) may have masked the influence of substances on injury severity. The aim was to analyze the effect of stimulant, hallucinogenic and depressant drugs other than alcohol on injury severity in trauma patients. Methods: The presence of alcohol, stimulant drugs (cocaine, amphetamines and methamphetamines), depressant drugs (benzodiazepines, opiates, methadone and barbiturates) and hallucinogenic drugs (THC and PCP) was analyzed in 1187 patients between 16 and 70 years old admitted to a trauma hospital between November 2012 and June 2015. Injury severity was determined prospectively as the Injury Severity Score. A multivariate analysis was used to quantify the strength of association between exposure to substances and trauma severity, using the presence of alcohol as a stratification variable. Results: Drugs other than alcohol were found in 371 patients (31.3%): 32 (2.7%) stimulants, 186 (15.3%) depressants, 78 (6.6%) hallucinogenics and 75 (5.6%) polydrug use. The presence of CNS depressant substances was associated with increased injury severity only in patients also exposed to alcohol, with an adjusted odds ratio of 4.63 (1.37-15.60) for moderate injuries and 7.83 (2.53-24.21) for severe. Conclusion: CNS depressant drugs had a strong influence on injury severity in patients who screened positive for alcohol consumption

Objetivo: No está claro qué efecto tienen las drogas distintas del alcohol sobre la gravedad de los traumatismos. Los análisis incluidos en estudios previos, que agrupan sustancias con efectos opuestos sobre el sistema nervioso central (SNC), pueden haber enmascarado la influencia de estas sobre la gravedad. El objetivo fue analizar el efecto de las drogas alucinógenas, estimulantes y depresoras del SNC, diferentes del alcohol, sobre la gravedad de las lesiones en pacientes ingresados por traumatismos. Métodos: Se analizó la presencia de alcohol, drogas estimulantes (cocaína, anfetaminas y metanfetaminas), depresoras (benzodiacepinas, opiáceos, metadona y barbitúricos) y alucinógenas (THC y PCP) en 1187 pacientes de entre 16 y 70 años de edad ingresados por traumatismo de noviembre de 2012 a junio de 2015. La gravedad del traumatismo se determinó prospectivamente mediante la Injury Severity Score. Se cuantificó la fuerza de la asociación entre la exposición a sustancias y la gravedad del traumatismo mediante un análisis multivariante, utilizando la presencia de alcohol como variable de estratificación. Resultados: Se encontraron drogas diferentes del alcohol en 371 pacientes (31,3%): 186 (15,3%) depresoras, 78 (6,6%) alucinógenas, 32 (2,7%) estimulantes y 75 (5,6%) combinadas. La presencia de sustancias depresoras del SNC se asoció con un aumento de la gravedad del traumatismo solo en pacientes también expuestos al alcohol, con una odds ratio ajustada de 4,63 (1,37-15,6) para lesiones moderadas y de 7,83 (2,53-24,21) para lesiones graves. Conclusión: Las drogas depresoras del SNC tuvieron una fuerte influencia en la gravedad del traumatismo en los pacientes que además presentaban resultados positivos para consumo de alcohol